Paciaroni, K.; Campagna, S.; Villiva’, N.; Maffini, E.; Celesti, F.; Tordi, A.; Lombardi, M.; Dragonetti, G.; Caravita di Toritto, T. THE Co-Occurrence of Jak2 Calr-Positive Myeloproliferative Disorder and Bcr-Abl-Positive Chronic Myelogenous Leukaemia Treated With Combination of Tyrosine Kinase Inhibitors and Ruxolitinib.: Dual Myeloid Disorder Treated With Two Drug Association. Mediterr J Hematol Infect Dis 2025, 17, e2025023.